04:22 AM EST, 02/06/2025 (MT Newswires) -- Belite Bio ( BLTE ) said late Wednesday it signed a securities purchase deal with a new healthcare investor to buy and sell 258,309 of its American depositary shares and warrants to buy equal amount of American depositary shares at $58.07 per ADS in a registered direct offering for gross proceeds of roughly $15 million.

The biopharmaceutical company intends to close the offering around Friday, and plans to use the net proceeds for working capital and general corporate purposes, it added.

Belite Bio's ( BLTE ) stock was down more than 1% in recent Thursday premarket activity.

Price: 57.11, Change: -0.96, Percent Change: -1.65